Abstract

PDB20 Cost of Cardiovascular Disease in TYPE2 Diabetes in France. a Nationwide Claims DATA Analysis

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
FGF23 in type 2 diabetic patients: relationship with bone metabolism and vascular disease.
Rebeca Reyes-Garcia ... Sonia Morales-Santana
Diabetes care | VOL. 37
Rebeca Reyes-Garcia, et. al.Rebeca Reyes-Garcia ... Sonia Morales-Santana
10 Apr 2014
Atherosclerotic Cardiovascular Disease in Type2 Diabetes: A Retrospective, Observational Study of Economic and Clinical Burden in Sweden.
Katarina Steen Carlsson ... Kristoffer Nilsson
Diabetes Therapy | VOL. 14
Katarina Steen Carlsson, et. al.Katarina Steen Carlsson ... Kristoffer Nilsson
16 Jun 2023
Prospective longitudinal characterisation of the relationship between diabetes and cardiac remodeling
A Chowdhary ... C Saunderson
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology | VOL. 22
A Chowdhary, et. al.A Chowdhary ... C Saunderson
13 Jul 2021
Diabetic cardiomyopathy: prevalence, determinants and potential treatments.
Gaurav S Gulsin ... Lavanya Athithan
Therapeutic Advances in Endocrinology and Metabolism | VOL. 10
Gaurav S Gulsin, et. al.Gaurav S Gulsin ... Lavanya Athithan
01 Jan 2019
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set
-
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
--
21 Jun 2024
Market entry agreements for innovative pharmaceuticals subject to indication broadening: a case study for pembrolizumab in the Netherlands.
Renaud J S D Heine ... Carin A Uyl-De Groot
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Renaud J S D Heine, et. al.Renaud J S D Heine ... Carin A Uyl-De Groot
21 Jun 2024
MSR99 A Stacked Ensemble Approach for Building Composite Measure Models in Healthcare
P Shi ... S Zhang
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
P Shi, et. al.P Shi ... S Zhang
15 Jun 2024
EE98 A Theory-Based Framework to Incorporate Health Equity in Economic Assessments
S Subramanian ... S Hoover
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
S Subramanian, et. al.S Subramanian ... S Hoover
15 Jun 2024
View more papers